PHARMA
Option Strategy before budget & quarterly result.Auro Pharma has announced 07.02.18 for results and the budget is on 01.02.18 so one can avoid the risk of volatility. The price has already moved down by 10% in last month. In this situation one can try the following strategy :
2/1 ratio call spread and put spread:
a. Buy 660 call 2 lots 14 to 17 range (Current-Price 15.20)
b. Sell 640 call 1 lot 21 to 26 range (Current-Price 22.30)
c. Buy 600 put 2 lots 14 to 17 range (Current-Price 15.15)
d. Sell 620 put 1 lot 21 to 26 range (Current-Price 22.65)
Max loss In the range of 2700 to 7500 if price consolidate 660 to 600 band post result
Profit 11000 to 18000 if price move above 706 or 555 post result
One should hold it for 10 working days or post result
Sun Pharma: Looking better Sun Pharma
Last time when stock was at 482, we were not very confident for a big move past 505.
The stock made a high of 509, came down till 466 and is now back at 483 levels. How ever this time the chart looks much better.
After the stock made a low of 432 on 14-Aug-2017, the stock has now given higher top (490---499---509) :: higher bottom (432--459 --466) so far
And if 460 /466 zone is held, the stock has every chance of making higher top breaking past the blue line (around 500 levels) & head higher towards 567 / 640 zone.
Take care & safe trading...!!!
DIVISLAB ShortThis stock has run up like no tomorrow lately.
Was a great run. Hope our community made some money off of it.
If not, worry not. Here is your chance!
Clear path to ~760, about 100 points down, is visible here.
Considering the overall bias that I have ( see the related trades), this one seems to be a very good short candidate.
If things pan out, this one will probably see a much more accelerated down move compared to the rest of the market because it has run up massively.
So there are long positions built up anxious about their profits. And there are opportunistic shorts like me. That's a double whammy.
My prediction, as can be seen on the chart, is 760 from 860 now.
Trade at your own risk.
Gennex Labs - Penny Stock - Buying OpportunityBeen tracking this pharma company since 2014 when it was trading at levels around Re.1
Since it being a penny stock it is difficult to apply technical analysis due to variety of reasons.
However, the yearly support trendline is now making sense and provides an opportunity to buy it at current levels.
Does it have a potential to be a multibagger - Who knows ? But currently there is a trading opportunity that i believe is worth the risk.
Trade Strategy :
Buy : 6.35
Target : 11.35
Stop Loss : 3.90
Risk to Reward - 2:1
Trade Safe !!!






















